The association between cognitive impairment and breast and colorectal cancer screening utilization.
Alzheimer’s disease
Colonoscopy
Dementia
Disparity
Mammogram
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
12 May 2021
12 May 2021
Historique:
received:
26
02
2021
accepted:
06
05
2021
entrez:
12
5
2021
pubmed:
13
5
2021
medline:
21
10
2021
Statut:
epublish
Résumé
Undergoing cancer screening is a debatable topic in patients with cognitive impairment. In this study, we aimed to examine the utilization and predictors of breast and colorectal cancer screening among screening eligible, cognitively impaired individuals. We analyzed the 2018 and 2019 National Health Interview Survey data (n = 12,965 and 24,782, respectively) on individuals eligible for breast or colorectal cancer screening. We calculated the percentage of cancer screening eligible individuals who received mammogram or colonoscopy by cognitive impairment status. We used multivariable logistic regression to examine whether having a recent mammogram or colonoscopy differed by cognitive impairment status, adjusting for covariates. We observed a significantly lower percentage of mammogram use in the screening eligible, cognitively impaired (mild or severe) versus unimpaired women. Adjusting for the covariates, the cognitively impaired women, mild (odds ratio [OR] = 0.85; p = 0.015) or severe (OR = 0.54; p < 0.001), were less likely to have had a recent mammogram compared to the cognitively unimpaired women. Although statistically non-significant, the percentage of colonoscopy use in the screening eligible, cognitively impaired individuals were slightly higher than that in the cognitively unimpaired individuals. In the regression analysis, we found the cognitively impaired men, mild (OR = 0.79; p < 0.001) or severe (OR = 0.69; p = 0.038), were less likely to have had a recent colonoscopy compared to the cognitively unimpaired men. More studies are needed to examine the multilevel factors that underpin the difference in cancer screening utilization in this vulnerable population. Our results highlight the need for additional research to address utilization and effectiveness of cancer screening in individuals with cognitive impairment.
Sections du résumé
BACKGROUND
BACKGROUND
Undergoing cancer screening is a debatable topic in patients with cognitive impairment. In this study, we aimed to examine the utilization and predictors of breast and colorectal cancer screening among screening eligible, cognitively impaired individuals.
METHODS
METHODS
We analyzed the 2018 and 2019 National Health Interview Survey data (n = 12,965 and 24,782, respectively) on individuals eligible for breast or colorectal cancer screening. We calculated the percentage of cancer screening eligible individuals who received mammogram or colonoscopy by cognitive impairment status. We used multivariable logistic regression to examine whether having a recent mammogram or colonoscopy differed by cognitive impairment status, adjusting for covariates.
RESULTS
RESULTS
We observed a significantly lower percentage of mammogram use in the screening eligible, cognitively impaired (mild or severe) versus unimpaired women. Adjusting for the covariates, the cognitively impaired women, mild (odds ratio [OR] = 0.85; p = 0.015) or severe (OR = 0.54; p < 0.001), were less likely to have had a recent mammogram compared to the cognitively unimpaired women. Although statistically non-significant, the percentage of colonoscopy use in the screening eligible, cognitively impaired individuals were slightly higher than that in the cognitively unimpaired individuals. In the regression analysis, we found the cognitively impaired men, mild (OR = 0.79; p < 0.001) or severe (OR = 0.69; p = 0.038), were less likely to have had a recent colonoscopy compared to the cognitively unimpaired men. More studies are needed to examine the multilevel factors that underpin the difference in cancer screening utilization in this vulnerable population.
CONCLUSION
CONCLUSIONS
Our results highlight the need for additional research to address utilization and effectiveness of cancer screening in individuals with cognitive impairment.
Identifiants
pubmed: 33975576
doi: 10.1186/s12885-021-08321-6
pii: 10.1186/s12885-021-08321-6
pmc: PMC8114528
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
539Subventions
Organisme : NCCDPHP CDC HHS
ID : U18 DP006512
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA245858
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA246418
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA207361
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG068717
Pays : United States
Références
Ann Intern Med. 2014 Mar 4;160(5):330-8
pubmed: 24378917
J Am Geriatr Soc. 2003 May;51(5 Suppl Dementia):S281-8
pubmed: 12801384
Psychogeriatrics. 2014 Sep;14(3):196-201
pubmed: 25323961
Int J Geriatr Psychiatry. 2005 Sep;20(9):827-34
pubmed: 16116577
Public Health Rep. 1996 May-Jun;111(3):244-50
pubmed: 8643816
J Gerontol B Psychol Sci Soc Sci. 2003 May;58(3):S179-86
pubmed: 12730319
Health Psychol. 1996 Nov;15(6):423-9
pubmed: 8973921
JAMA. 2016 Jun 21;315(23):2564-2575
pubmed: 27304597
Ann Epidemiol. 2019 Dec;40:35-36.e1
pubmed: 31732229
JAMA. 2018 Aug 21;320(7):674-686
pubmed: 30140884
Am J Prev Med. 2005 May;28(4):351-6
pubmed: 15831340
Ann Fam Med. 2003 Nov-Dec;1(4):209-17
pubmed: 15055410
Cancer. 2011 Aug 15;117(16):3850-9
pubmed: 21319155
Prev Chronic Dis. 2017 Jan 26;14:E09
pubmed: 28125399
J Aging Health. 1997 Aug;9(3):334-54
pubmed: 10182397
Crit Rev Oncol Hematol. 2010 Jun;74(3):218-24
pubmed: 19709899
J Womens Health (Larchmt). 2015 Jul;24(7):593-601
pubmed: 26083235
Dement Geriatr Cogn Dis Extra. 2013 Sep 28;3(1):320-32
pubmed: 24174927
Arch Intern Med. 2007 Feb 12;167(3):258-64
pubmed: 17296881
J Health Care Poor Underserved. 2004 Nov;15(4):688-702
pubmed: 15531824
Am J Public Health. 2010 Oct;100(10):1917-23
pubmed: 20075325
J Int Neuropsychol Soc. 2018 Sep;24(8):842-853
pubmed: 30278855
Am J Public Health. 2015 Feb;105(2):408-13
pubmed: 25033130
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):748-57
pubmed: 18381468
J Am Geriatr Soc. 2004 Mar;52(3):440-4
pubmed: 14962162
Ann Intern Med. 2016 Feb 16;164(4):279-96
pubmed: 26757170
BMC Cancer. 2018 Sep 20;18(1):906
pubmed: 30236083